Report Code: A12686 | Pages: NA | ||
Tables: NA | Charts: NA |
|
The ventricular restoration system is different from the conventional surgical reconstructive procedure and is a less invasive method for heart failure patients. Cardiovascular diseases are on a consistent rise in countries across the globe. Numerous advancements have been made in the cardiac field to provide better care. Ambulatory surgical centers and hospitals provide these restoration systems. Several factors such as changing lifestyle, the rise in obesity, technological novelty, increase in rates of heart-related diseases, rise in aged population, and surge in funding in the healthcare sector are driving the market forward.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the ventricular restoration systems market.
Top Impacting Factors
Ventricular Restoration Systems Market Trends
New product launches to flourish the market
In November 2020, Abbott Laboratories launched a new clip delivery system for minimally invasive treatment of leaky mitral valves. Leaky mitral valves repaired by these clips without open-heart surgery, delivered through any vein in the leg.
In February 2020, Xeltis AG showcased RESTOREXTM technology at the Spirit of Berne Conference in Switzerland. It permits patients needing cardiovascular replacement to produce new living blood vessels or heart valves made from their own tissue
Key Benefits of the Report
Questions answered in the ventricular restoration systems Report
Ventricular Restoration Systems Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | ON-X LIFE TECHNOLOGIES INC, Neochord Inc., CardioKinetics Inc, Edwards Lifesciences Corp., Bioventrix Inc., Xeltis AG, Abbott, Medtronic, CryoLife Inc., Valtech |
Loading Table Of Content...
Start reading.
This Report and over 71,233+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers